These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39245798)

  • 1. A multicentre clinical trial evaluating the outcomes of two application regimens of a unique keratin-based graft in the treatment of Wagner grade one non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Carter MJ; Hanft J; Surprenant M; Isaac AL; Zelen CM
    Int Wound J; 2024 Sep; 21(9):e70029. PubMed ID: 39245798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter retrospective study comparing a polylactic acid CAMP with intact fish skin graft or a collagen dressing in the management of diabetic foot ulcers and venous leg ulcers.
    Liden BA; Liu T; Regulski M; Foster M; DeLeon R; Palazzi G; Ramirez-GarciaLuna JL
    Wounds; 2024 Sep; 36(9):297-302. PubMed ID: 39378347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
    Serena TE; Bullock NM; Cole W; Lantis J; Li L; Moore S; Patel K; Sabo M; Wahab N; Price P
    J Wound Care; 2021 May; 30(Sup5):S7-S14. PubMed ID: 33979229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; Zelen CM
    Int Wound J; 2020 Aug; 17(4):966-973. PubMed ID: 32266774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial.
    Snyder R; Nouvong A; Ulloa J; Wahab N; Treadwell T; Bruwer F; Naude L; McGuire J; Reyzelman AM; Graham T; ; Lessing R; Lullove E; Ozker E; Pham HT; Pasternac M; Cohen S
    J Wound Care; 2024 Sep; 33(9):688-700. PubMed ID: 39287414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a dual-layer amniotic membrane in the treatment of diabetic foot ulcers: an observational study.
    Sledge I; Maislin D; Bernarducci D; Snyder R; Serena TE
    J Wound Care; 2020 Sep; 29(Sup9):S8-S12. PubMed ID: 32924804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials.
    Galiano R; Snyder R; Mayer P; Rogers LC; Alvarez O;
    J Wound Care; 2019 Jun; 28(6):383-395. PubMed ID: 31166864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
    Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
    J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of dehydrated human amniotic membrane allografts in patients with DFUs.
    Zelen CM
    J Wound Care; 2013 Jul; 22(7):347-8, 350-1. PubMed ID: 24159656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Meta-Analysis of the Outcomes of Metatarsal Head Resection for the Treatment of Neuropathic Diabetic Foot Ulcers.
    Yammine K; Kheir N; Assi C
    Adv Wound Care (New Rochelle); 2021 Feb; 10(2):81-90. PubMed ID: 32870773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.